Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
Read more
Bayer has announced that the HSE has granted hospital pricing approval for EYLEA® 8mg for eligible adult patients with wet age-related macular degeneration and diabetic macular oedema in Ireland.
Read more
Penthrox (methoxyflurane) is now licensed for use in children aged six and over in Ireland, expanding emergency trauma pain relief options in hospital and pre-hospital settings.
Read more
Nordic Pharma has announced the European launch of Lacrifill®, a CE-marked canalicular gel designed to enhance tear film preservation in patients with dry eye disease.
Read more
PADCEV (enfortumab vedotin) plus Keytruda has demonstrated significant improvements in event-free and overall survival in patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility.
Read more
Uniphar has announced the acquisition of Irish health technology provider TouchStore, supporting further digital innovation across medicines supply and dispensing systems.
Read more
Teclistamab, an off-the-shelf (ready to use) subcutaneously administered therapy, induced deep and rapid responses in triple-class exposed patients with relapsed
Read more
Teva Pharmaceuticals is pleased to announce the launch of Fingolimod Teva, a generic high tech prescription medication indicated for multiple
Read more
Teva Pharmaceuticals is pleased to announce the launch of Varenicline Teva, a generic prescription medication indicated for smoking cessation. Varenicline
Read more
Clonmel Healthcare are delighted to announce the introduction of Uzpruvo®, the new Ustekinumab biosimilar. Uzpruvo® will be marketed from July
Read more